Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SDZ-WAG 994 is an adenosine A1 receptor agonist.1 It selectively binds to adenosine A1 receptors over adenosine A2 receptors (Kds = 19.95 and 25,109 nM, respectively) and induces adenylate cyclase activity in rat adipocyte membranes (EC50 = 398 nM). In vivo, SDZ-WAG 994 (0.14-1.4 µmol/kg) induces hypotension and bradycardia in spontaneously hypertensive rats.
WARNING This product is not for human or veterinary use.
1. General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist. Drug Dev. Res. 34(3), 276-288 (1995).